Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | PHGE | Common Stock, $0.0001 par value | 3.64M | Jul 28, 2021 | By SymBiosis, LLC | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | PHGE | Warrants to purchase Common Stock | Jul 28, 2021 | Common Stock | 1.88M | $5.00 | By SymBiosis, LLC | F2 |
Id | Content |
---|---|
F1 | These shares of common stock are beneficially owned by the reporting person include (i) 1,137,846 shares of common stock already beneficially owned by the reporting person prior to July 28, 2021, and (ii) 2,500,000 shares of common stock beneficially owned by the reporting person that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021. The securities are directly held by SymBiosis, LLC, over which the reporting person exercises sole investment power. |
F2 | The warrants are directly held by SymBiosis, LLC, over which the reporting person exercises sole investment power. |